Clinical Trial Update: First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure [EARLY_Phase 1]

View source ↗

Summary

This is a first-in-human pilot study testing an epicardial circular RNA-HM2002 injection used during coronary artery bypass grafting for ischemic heart disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• Epicardial circular RNA-HM2002 injection (circular RNA-HM2002)

Snippet

Sponsor: Ruijin Hospital | Conditions: Ischaemic Heart Disease, Heart Failure | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING